Two young women with severe Danon disease initially suspected to have cardiac amyloidosis: a case report and literature review
- 1Department of Pathology, West China Hospital, Sichuan University
- 2Department of Pathology, West China Xiamen Hospital
- 3Department of Cardiology, West China Hospital, Sichuan University
Abstract
Background: Danon disease is a rare X-linked dominant lysosomal storage disorder caused by LAMP2 mutations and characterized by cardiomyopathy, skeletal myopathy, and intellectual disability. This study reports two Chinese cases of Danon disease that were initially suspected as cardiac amyloidosis.
Methods: Clinical data were collected, LAMP2 genetic analysis was performed and literatures were reviewed.
Results: Both patients presented with mainly cardiac symptoms in adulthood. Laboratory tests showed elevated levels of creatine kinase isoenzyme, troponin T, lactate dehydrogenase, hydroxybutyrate dehydrogenase, aspartate aminotransferase, and N-terminal pro-B-type natriuretic peptide. Cardiac MRI revealed diffuse left ventricular wall thickening and myocardial late gadolinium enhancement. Histopathology showed hypertrophied cardiomyocytes with disarray, vacuolar degeneration, enlarged, hyperchromatic nuclei, and fibrosis. Electron microscopy demonstrated autophagic vacuoles with sarcolemmal features-like structures, myelin-like figures resembling zebra bodies and accumulation of glycogen granules. Immunohistochemistry showed partial loss of LAMP2 expression. Genetic testing identified two rare heterozygous LAMP2 variants: c.3G > T in exon 1 (variant of uncertain significance) and c.446del in exon 4 (likely pathogenic). Both patients underwent heart transplantation and remained alive at follow-up.
Conclusions: These rare LAMP2 variants expand the mutational spectrum of Danon disease and highlight the need for genetic counseling. Endomyocardial biopsy is valuable for diagnosis, while genetic testing is required for definitive confirmation.
Related
- New-Onset Graves’ Disease in the Postpartum Period Initially Suspected to Represent Postpartum Thyroiditis
- Endomyocardial biopsy after leadless pacemaker implantation in patient with suspected cardiac amyloidosis
- Managing Cardiac Amyloidosis in a Rural Cardiology Practice: Bridging Gaps in Specialized Evaluation and Disease-Modifying Treatment
- Long-term Prognostic Value of Stress Phase Entropy for Predicting Major Cardiac Events in Patients with Known or Suspected Coronary Artery Disease
- Dual cardiac amyloidosis with AL cardiomyopathy and ATTR cardiomyopathy in systemic AL amyloidosis: Recommendation for a myocardial histology-based diagnosis
BibTeX
@article{yu2026young,
title = {{Two young women with severe Danon disease initially suspected to have cardiac amyloidosis: a case report and literature review}},
author = {Tianping Yu and Xin Xie and Xiuyi Pan and Ting Yu and Yanyan Su and Yang Li and Yucheng Chen and Xueqin Chen},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
month = oct,
doi = {10.3389/fcvm.2026.1934783},
url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1934783/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Two young women with severe Danon disease initially suspected to have cardiac amyloidosis: a case report and literature review
AU - Tianping Yu
AU - Xin Xie
AU - Xiuyi Pan
AU - Ting Yu
AU - Yanyan Su
AU - Yang Li
AU - Yucheng Chen
AU - Xueqin Chen
PY - 2026
DA - 2026/10/26
JO - Frontiers in Cardiovascular Medicine
DO - 10.3389/fcvm.2026.1934783
UR - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1934783/full
AB - Background: Danon disease is a rare X-linked dominant lysosomal storage disorder caused by LAMP2 mutations and characterized by cardiomyopathy, skeletal myopathy, and intellectual disability. This study reports two Chinese cases of Danon disease that were initially suspected as cardiac amyloidosis. Methods: Clinical data were collected, LAMP2 genetic analysis was performed and literatures were reviewed. Results: Both patients presented with mainly cardiac symptoms in adulthood. Laboratory tests showed elevated levels of creatine kinase isoenzyme, troponin T, lactate dehydrogenase, hydroxybutyrate dehydrogenase, aspartate aminotransferase, and N-terminal pro-B-type natriuretic peptide. Cardiac MRI revealed diffuse left ventricular wall thickening and myocardial late gadolinium enhancement. Histopathology showed hypertrophied cardiomyocytes with disarray, vacuolar degeneration, enlarged, hyperchromatic nuclei, and fibrosis. Electron microscopy demonstrated autophagic vacuoles with sarcolemmal features-like structures, myelin-like figures resembling zebra bodies and accumulation of glycogen granules. Immunohistochemistry showed partial loss of LAMP2 expression. Genetic testing identified two rare heterozygous LAMP2 variants: c.3G > T in exon 1 (variant of uncertain significance) and c.446del in exon 4 (likely pathogenic). Both patients underwent heart transplantation and remained alive at follow-up. Conclusions: These rare LAMP2 variants expand the mutational spectrum of Danon disease and highlight the need for genetic counseling. Endomyocardial biopsy is valuable for diagnosis, while genetic testing is required for definitive confirmation.
SN - 2297-055X
ER -